The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States on indications of patients who undergo magnetic resonance imaging (MRI) and radiation exposure with cardiovascular implantable electronic devices (CIEDs). The expert writing group presented the recommendations included in the 2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Search for "" returned 6 matches
Today, the Heart Rhythm Society (HRS) in joint partnership with the European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) issued an international consensus statement that provides a state-of-the-art review of the indications, techniques, and outcomes of catheter and surgical ablation of atrial fibrillation (AF). The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, first issued in 2007, and again in 2012, represents a state-of-the art review of the field of catheter and surgical ablation of AF. This document is a complete and comprehensive revision of the 2012 statement and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Today, Heart Rhythm 2017, the Heart Rhythm Society’s (HRS) 38th Annual Scientific Sessions, kicks off at McCormick Place in Chicago where leading clinicians, scientists, researchers, educators and innovators from around the world present and discuss groundbreaking research for the care of cardiac arrhythmias. The theme of this year’s meeting is “Together We Can” to reinforce the importance of global collaboration to propel the field of electrophysiology (EP) forward.
A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in treating ventricular arrhythmias for pediatric patients who are at risk for sudden cardiac death (SCD). The study represents the largest pediatric patient population to date when evaluating the WCD as a therapy option. The findings of the study were presented today at Heart Rhythm 2017, the Heart Rhythm’s 38th Annual Scientific Sessions.
A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial intelligence-based algorithm, can detect a serious and often symptomless heart arrhythmia, atrial fibrillation (AF). The new research uses a deep neural network based on photoplethysmographic (PPG) sensors commonly found in smart watches. The results of this study were presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Heart Rhythm 2016, the Heart Rhythm Society’s (HRS) 37th Annual Scientific Sessions and this year’s leading conference on cardiac arrhythmias, commences at the Moscone Center. The meeting focuses on the importance of collaboration to propel the field of cardiac pacing and electrophysiology (EP) forward. HRS is the only organization that brings together the world’s leading clinicians, scientists and allied health professionals to help end death and suffering from heart rhythm disorders.